EUCTR2008-003727-23-GB进行中（未招募）1 期
Does phosphate binding with sevelamer carbonate improve cardiovascular structure and function in patients with early chronic kidney disease? - Effects of phosphate binding in stage 3 chronic kidney disease
niversity Hospital Birmingham NHS Foundation Trust0 个研究点目标入组 120 人开始时间: 2010年12月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Chronic kidney disease stage 3 (eGFR 30-59 ml/min/1.73m2)
- •Age 18-80 years
- •Well controlled blood pressure (<140/90 mmHg)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diabetes mellitus
- •Bowel obstruction
- •Dysphagia/swallowing disorders
- •Severe gastrointestinal motility disorders
- •Existing or previous treatment within 1 year with a phosphate binder or vitamin D analogue
- •Hypophosphataemia (serum phosphate <0.8 mmol/l)
- •Uncontrolled hyperphosphataemia (serum phosphate >1.8 mmol/L)
- •Uncontrolled secondary hyperparathyroidism (PTH >80 pg/ml)
研究者
相似试验
终止
不适用
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET ScanDialysisInflammationCardiovascular DiseaseAtherosclerosisHyperphosphatemiaNCT01238588Brigham and Women's Hospital24
已完成
2 期
Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney DiseaseCardiovascular DiseasesKidney Failure, ChronicNCT00806481University Hospital Birmingham NHS Foundation Trust120
已完成
3 期
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseChronic Kidney DiseaseHyperparathyroidismNCT01191762Kenneth R. Phelps, M.D.30
已完成
4 期
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis PatientsCalcinosisHyperparathyroidism, SecondaryArteriosclerosisNCT00211939Nabi Biopharmaceuticals203
已完成
3 期
Comparing the effect of sevelamer carbonate and sevelamer hydrochloride on blood level of phosphate, Ca, ph, bicarbonate and gastrointestinal complications in patients undergoing maintenance hemodialysisIRCT20141016019554N13Zanjan University of Medical Sciences44